BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22371452)

  • 41. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).
    Mao Y; Zhang DW; Zhu H; Lin H; Xiong L; Cao Q; Liu Y; Li QD; Xu JR; Xu LF; Chen RJ
    Diagn Pathol; 2012 Dec; 7():178. PubMed ID: 23237707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
    Tao Y; Song X; Deng X; Xie D; Lee LM; Liu Y; Li W; Li L; Deng L; Wu Q; Gong J; Cao Y
    Exp Cell Res; 2005 Feb; 303(2):240-51. PubMed ID: 15652339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.
    Wu T; Wang S; Wu J; Lin Z; Sui X; Xu X; Shimizu N; Chen B; Wang X
    J Exp Clin Cancer Res; 2015 Feb; 34(1):17. PubMed ID: 25887673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
    Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.
    Imai A; Takase H; Imadome KI; Matsuda G; Ohnishi I; Yamamoto K; Kudo T; Tanaka Y; Maehara T; Miura O; Arai A
    Intern Med; 2017; 56(11):1409-1414. PubMed ID: 28566607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
    Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
    Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells.
    Ian MX; Lan SZ; Cheng ZF; Dan H; Qiong LH
    Cancer Biol Ther; 2008 Oct; 7(10):1602-6. PubMed ID: 18769118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
    Diamantopoulos PT; Polonyfi K; Sofotasiou M; Mantzourani M; Galanopoulos A; Spanakis N; Papadopoulou V; Kalala F; Iliakis T; Zareifi DS; Kodandreopoulou E; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Terpos E; Variami E; Kollia P; Vaiopoulos G; Pangalis G; Viniou NA
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):56-60. PubMed ID: 24262330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
    Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
    Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
    Halabi MA; Jaccard A; Moulinas R; Bahri R; Al Mouhammad H; Mammari N; Feuillard J; Ranger-Rogez S
    Int J Cancer; 2016 Aug; 139(4):793-802. PubMed ID: 27061907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
    Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
    Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
    Terrin L; Dal Col J; Rampazzo E; Zancai P; Pedrotti M; Ammirabile G; Bergamin S; Rizzo S; Dolcetti R; De Rossi A
    J Virol; 2008 Oct; 82(20):10175-87. PubMed ID: 18684838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of Epstein-Barr virus in breast carcinomas in Tunisia.
    Hachana M; Amara K; Ziadi S; Romdhane E; Gacem RB; Trimeche M
    Pathol Res Pract; 2011 Nov; 207(11):695-700. PubMed ID: 22024152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
    Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
    Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1.
    Kim JE; Kim YA; Jeon YK; Park SS; Heo DS; Kim CW
    Pathol Int; 2003 Nov; 53(11):735-43. PubMed ID: 14629296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization.
    Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T
    Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.